Rebecca Lalani is a well-educated professional with a background in pharmacy, biochemistry, and molecular biology. She studied Doctor of Pharmacy at the University of Michigan College of Pharmacy and Bachelor's degree in Biochemistry and Molecular Biology at the University of California, Berkeley. Lalani has worked in various organizations, including Ultragenyx Pharmaceutical Inc., Gilead Sciences, Bayer HealthCare, Rutgers University, and Abbott Laboratories.

Currently, Lalani works as the Associate Director of Regulatory Affairs Strategy and Clinical Development at Ultragenyx Pharmaceutical Inc. Before that, she worked as the Senior Manager of Regulatory Affairs Strategy and Clinical Development at the same company. She has also worked in Gilead Sciences as the Regulatory Affairs - Advertising and Promotion and, in Bayer HealthCare, as the Regulatory Affairs Post-Doctoral Fellow. Lalani has an experience of working as the Adjunct Professor at Rutgers University, and as a Global Regulatory Affairs, Advertising & Promotions Intern at Abbott Laboratories.

Lalani has extensive experience and expertise in regulatory affairs, clinical development, advertising and promotion, and pharmacy. She has a keen interest in the pharmaceutical industry and has worked in various capacities to gain expertise in the field.